The first stop for professional medicines advice

COVID-19 Medicines Optimisation: Specialty Guidance

36 results

RelevanceNewest firstOldest firstTitle
Applied filters

NICE Rapid Evidence summary for anakinra for COVID-19 associated secondary haemophagocytic lymphohistiocytosis

26 May 2021A summary of the evidence on the use of anakinra for treatment of haemophagocytic lymphohistiocytosis secondary to COVID-19 infection.

Allergy UK FAQs during COVID-19

26 May 2021A summary of the Allergy UK Frequently Asked Questions on coronavirus aimed at people living with allergy.

NICE Rapid Guideline for management of children and young people who are immunocompromised during COVID-19

26 May 2021This guideline advises on how to maximise the safety of immunocompromised children and young people during the COVID-19 pandemic.

Summary of COVID-19 medicines guidance: Haematological disorders

19 May 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and haematological disorders. Our advice…

Summary of COVID-19 medicines guidance: Obstetrics and gynaecology

19 May 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and obstetrics and gynaecology. Our…

Summary of COVID-19 medicines guidance: Endocrine system disorders

13 May 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and endocrine system disorders. Our…

Summary of COVID-19 medicines guidance: Later life

11 May 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and later life disorders. Our…

Summary of COVID-19 medicines guidance: Learning disabilities

11 May 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and learning disabilities. Our advice…

Summary of COVID-19 medicines guidance: Diabetes

11 May 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and diabetes. Our advice is…

Summary of COVID-19 medicines guidance: Skin disorders

10 May 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and skin disorders. Our advice…